Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BPTH is a very mispriced security, long term 4-5 is very doable
LSG hitting that 1.00 Trigger
AXU looking to break .42 just a tad more volume would be good,
GTHP looking good so far
GTHP, thank you,stopped out of AXU at .37 chart looked good but volume was lacking.
My bad it is an OTC so not for this board.
AXU is trying needs a bit more volume me thinks,when you get a min can you check the GTHP chart its also banging on the 50MA
AXU is really wanting that 50ma
Locking gains is the name of the game,take it,for although it was only 1.6% of my portfolio still a good wake up to keep on my toes
Nice work,i took my eye off the ball on this one,badly traded
I think still trading in canada plus its a T1 HALT so not sure what kind of news
Not sure could not get any worse could it? got out yesterday with a loss 1300,funny thing is i was up 2000 shheesh,lesson learned moving on
kichwa
PAL halted news pending
http://www.nasdaqtrader.com/Trader.aspx?id=Tradehalts
In 2010, we entered into a collaboration agreement with Takeda to develop and commercialize NB32 in the United States, Canada and Mexico. We have received $50.0 million from Takeda and we are eligible to receive additional payments of over $1.0 billion upon achieving certain milestones, including $100.0 million that can be achieved between the approval and the first commercial sale of NB32 in the United States. The collaboration agreement provides that Takeda will be responsible for commercialization costs and activities.
We are considering potential partnership opportunities for Empatic as well as NB32 outside of the United States, Canada and Mexico
Thanks BioLaw
Just saw that,should see a bounce into the Adcom meet,
K1
I hear you!
I had the same 'Oh crap' moments with the 6mil sell and not finding the Adcom on the FDA site,so decided to bail let the dust settle and see what's what!had 6k shares small loss but in the current climate i'll take my licks and live to fight another day.I will look to re enter if i feel things sit right if not will move on.
K1
Thank you Markjohn62!
Good info thanks,i bailed out will look to re enter once the selling is done
K1
Adcom!
Been looking at the Confirmed Scheduled Advisory Meetings and i dont see the 14-15 nov meeting that DVAX should be! any one know if its cancelled or postponed?or am i looking in the wrong place?
[url]www.fda.gov/AdvisoryCommittees/Calendar/default.htm
K1
To unstable for me,
Glta that are still holding.
Out at 15.205 from an entry of 11.06,
moving on
k1
Trading will resume at 14.40
http://www.nasdaqtrader.com/Trader.aspx?id=TradingHaltSearch
K1
CBRX. Thanks for that,i could see the indicators point north,just was not sure where support was,grabbed a starter at .85 yesterday.
Hey IcucTrader
Hope your having a good 2012,just wanted to ask if you could have a look at the CBRX chart for me,am looking for an entry and i see .83 ish for a good run.
Thanks
K1
$heff,Barefootrunner,Investor100,
Would like to extend my profound gratitude to you fine fellows and to all the contributors to this board,I like the wealth of experience and DD that is provided here,invaluable.
Thank you from across the pond,
Have a fine weekend
k1
Thanks chevyman,
Il keep scouring the web see if i can find it.
K1
Chevyman hi,
Do you or anyone have a link to the case dismissal?would like to read the whole doc in its entirety,
Thanks.
K1.
SMF
This line is Not quite true,
"Even as a layman I understand that equivalence can only be demonstrated by comparing identical (not just equivalent) subjects"
Direct fron the FDA web site
A claim of substantial equivalence does not mean the new and predicate devices must be identical. Substantial equivalence is established with respect to intended use, design, energy used or delivered, materials, chemical composition, manufacturing process, performance, safety, effectiveness, labeling, biocompatibility, standards, and other characteristics, as applicable.
K1
Ah some financing, good
Especially in theses days of austerity Dean has some financing to keep the lights on while he tries to get the DVIS past the FDA,may not be the best deal out there,but a deal none the less.
K1
"The repurchase program is expected to continue over the next twelve (12) months unless extended or shortened by the Board of Directors."
Lets see 24th march would make that 6 months ish,quick tap on calculator gives them another 6 months ish to fulfill that unless they extend or indeed shorten it.
A step in the right direction indeed,
Perhaps Dean is a step or two ahead?
Good afternoon sir
I think you'll find your good Dr Ohbayashi has,i think they claimed to have developed the first real time 3d thingy.
K1
Homer Hi,
Going to see the demo was good DD period ,more so in the case of IMGG where there was doubt as to the existence of the DVIS, and there was no violation of Reg FD as IMGG put out an 8K as per Reg FD which infact they did not have to as there was no info there that was non public.
K1
'Does IMGG have insurance to protect the company from risk of loss?
I would hope so seeing how much the last fire has cost them.
Thanks good explanation
Good news is always welcome,
Finally some vindication for Dean,he has taken some flak and granted a lot his own doing but hey the damn thing works and that should at least settle some nervous investors,said it before this is and has always been an FDA play,to much emphasis has been placed on matters though important but pointless if Dean did not have what he said he had,simply put if dean can now get past the final hurdle that is the FDA be it in 2011 or 2012 all the toxic financing anD give away ppm's,company buYback(they still have a few months to get in)directors selling(last count he still had 15 mill plus shares)mtv slots will be but a fading memory,as always trade/invest accordingly.
Good news is always welcome,
Finally some vindication for Dean,he has taken some flak and granted a lot his own doing but hey the damn thing works and that should at least settle some nervous investors,said it before this is and has always been an FDA play,to much emphasis has been placed on matters though important but pointless if Dean did not have what he said he had,simply put if dean can now get past the final hurdle that is the FDA be it in 2011 or 2012 all the toxic financing anD give away ppm's,company buYback(they still have a few months to get in)directors selling(last count he still had 15 mill plus shares)mtv slots will be but a fading memory,as always trade/invest accordingly.
Hmm volume is nada will wait for now.
Thanks
Agreed the $5 mark looks suitable,might try and jump in a tad before,i feel they might be good volume with the FDA coming early on ANX with sideliners jumping in for a push,
k1
Hey icuc,
Just wondered what your thoughts were on the PATH chart,looking for an entry a s it has a pdufa date end on the month,but as with ANX the FDA may come early so am looking to get in and out before the catalyst.i was quite fortunate with ANX was in and out b4 close of play yesterday.
k1